Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Bialer, M; Johannessen, SI; Kupferberg, HJ; Levy, RH; Loiseau, P; Perucca, E
   Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V)
   EPILEPSY RESEARCH
   
   M. Bialer et al., "Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V)", EPILEPSY R, 43(1), 2001, pp. 11-58
2. Wasserman, M; Yagen, B; Blotnik, S; Papo, N; Bialer, M
   Stereoselective pharmacokinetic analysis and antiepileptic activity of N-2-hydroxypropyl valpromide, a central nervous system-active chiral valproylamide
   THERAPEUTIC DRUG MONITORING
   
   M. Wasserman et al., "Stereoselective pharmacokinetic analysis and antiepileptic activity of N-2-hydroxypropyl valpromide, a central nervous system-active chiral valproylamide", THER DRUG M, 23(4), 2001, pp. 414-420
3. Isoherranen, N; Yagen, T; Soback, T; Roeder, M; Schurig, V; Bialer, M
   Pharmacokinetics of levetiracetam and its enantiomer (R)-alpha-ethyl-2-oxo-pyrrolidine acetamide in dogs
   EPILEPSIA
   
   N. Isoherranen et al., "Pharmacokinetics of levetiracetam and its enantiomer (R)-alpha-ethyl-2-oxo-pyrrolidine acetamide in dogs", EPILEPSIA, 42(7), 2001, pp. 825-830
4. Isoherranen, N; Woodhead, JH; White, HS; Bialer, M
   Anticonvulsant profile of valrocemide (TV1901): A new antiepileptic drug
   EPILEPSIA
   
   N. Isoherranen et al., "Anticonvulsant profile of valrocemide (TV1901): A new antiepileptic drug", EPILEPSIA, 42(7), 2001, pp. 831-836
5. Isoherranen, N; Roeder, M; Soback, S; Yagen, B; Schurig, V; Bialer, M
   Enantioselective analysis of levetiracetam and its enantiomer R-alpha-ethyl-2-oxo-pyrrolidine acetamide using gas chromatography and ion trap mass spectrometric detection
   JOURNAL OF CHROMATOGRAPHY B
   
   N. Isoherranen et al., "Enantioselective analysis of levetiracetam and its enantiomer R-alpha-ethyl-2-oxo-pyrrolidine acetamide using gas chromatography and ion trap mass spectrometric detection", J CHROMAT B, 745(2), 2000, pp. 325-332
6. Volosov, A; Bialer, M; Sun, XD; Perucca, E; Sintov, A; Yagen, B
   Simultaneous stereoselective high-performance liquid chromatographic determination of 10-hydroxycarbazepine and its metabolite carbamazepine-10,11-trans-dihydrodiol in human urine
   JOURNAL OF CHROMATOGRAPHY B
   
   A. Volosov et al., "Simultaneous stereoselective high-performance liquid chromatographic determination of 10-hydroxycarbazepine and its metabolite carbamazepine-10,11-trans-dihydrodiol in human urine", J CHROMAT B, 738(2), 2000, pp. 419-425
7. Spiegelstein, O; Kroetz, DL; Levy, RH; Yagen, B; Hurst, SI; Levi, M; Haj-Yehia, A; Bialer, M
   Structure activity relationship of human microsomal epoxide hydrolase inhibition by amide and acid analogues of valproic acid
   PHARMACEUTICAL RESEARCH
   
   O. Spiegelstein et al., "Structure activity relationship of human microsomal epoxide hydrolase inhibition by amide and acid analogues of valproic acid", PHARM RES, 17(2), 2000, pp. 216-221
8. Lindekens, N; Smolders, I; Khan, GM; Bialer, M; Ebinger, G; Michotte, Y
   In vivo study of the effect of valpromide and valnoctamide in the pilocarpine rat model of focal epilepsy
   PHARMACEUTICAL RESEARCH
   
   N. Lindekens et al., "In vivo study of the effect of valpromide and valnoctamide in the pilocarpine rat model of focal epilepsy", PHARM RES, 17(11), 2000, pp. 1408-1413
9. Britzi, M; Bialer, M; Arcavi, L; Shachbari, A; Kapitulnik, J; Soback, S
   Genetic polymorphism of CYP2D6 and CYP2C19 metabolism determined by phenotyping Israeli ethnic groups
   THERAPEUTIC DRUG MONITORING
   
   M. Britzi et al., "Genetic polymorphism of CYP2D6 and CYP2C19 metabolism determined by phenotyping Israeli ethnic groups", THER DRUG M, 22(5), 2000, pp. 510-516
10. Spiegelstein, O; Yagen, B; Bennett, GD; Finnell, RH; Blotnik, S; Bialer, M
    Stereoselective pharmacokinetic analysis of valnoctamide, a CNS-active chiral amide analogue of valproic acid, in dogs, rats, and mice
    THERAPEUTIC DRUG MONITORING
    
    O. Spiegelstein et al., "Stereoselective pharmacokinetic analysis of valnoctamide, a CNS-active chiral amide analogue of valproic acid, in dogs, rats, and mice", THER DRUG M, 22(5), 2000, pp. 574-581
11. Volosov, A; Yagen, B; Bialer, M
    Comparative stereoselective pharmacokinetic analysis of 10-hydroxycarbazepine after oral administration of its individual enantiomers and the racemicmixture to dogs
    EPILEPSIA
    
    A. Volosov et al., "Comparative stereoselective pharmacokinetic analysis of 10-hydroxycarbazepine after oral administration of its individual enantiomers and the racemicmixture to dogs", EPILEPSIA, 41(9), 2000, pp. 1107-1111
12. Bialer, M
    From Vermont to Germany - The life of nurse Carolyne Reed, age 101.
    AMERICAN JOURNAL OF NURSING
    
    M. Bialer, "From Vermont to Germany - The life of nurse Carolyne Reed, age 101.", AM J NURS, 100(10), 2000, pp. 96T-96T
13. Roeder, M; Spiegelstein, O; Schurig, V; Bialer, M; Yagen, B
    Absolute configuration of the four stereoisomers of valnoctamide (2-ethyl-3-methylvaleramide), a potentially new stereospecific antiepileptic and CNSdrug
    TETRAHEDRON-ASYMMETRY
    
    M. Roeder et al., "Absolute configuration of the four stereoisomers of valnoctamide (2-ethyl-3-methylvaleramide), a potentially new stereospecific antiepileptic and CNSdrug", TETRAHEDR-A, 10(5), 1999, pp. 841-853
14. Sussan, S; Dagan, A; Blotnik, S; Bialer, M
    The structural requirements for the design of antiepileptic-glycine derivatives
    EPILEPSY RESEARCH
    
    S. Sussan et al., "The structural requirements for the design of antiepileptic-glycine derivatives", EPILEPSY R, 34(2-3), 1999, pp. 207-220
15. Bialer, M; Johannessen, SI; Kupferberg, HJ; Levy, RH; Loiseau, P; Perucca, E
    Progress report on new antiepileptic drugs: a summary of the fourth Eilat conference (EILAT IV)
    EPILEPSY RESEARCH
    
    M. Bialer et al., "Progress report on new antiepileptic drugs: a summary of the fourth Eilat conference (EILAT IV)", EPILEPSY R, 34(1), 1999, pp. 1-41
16. Sussan, S; Dagan, A; Bialer, M
    Pharmacokinetic analysis and anticonvulsant activity of glycine and glycinamide derivatives
    EPILEPSY RESEARCH
    
    S. Sussan et al., "Pharmacokinetic analysis and anticonvulsant activity of glycine and glycinamide derivatives", EPILEPSY R, 33(1), 1999, pp. 11-21
17. Spiegelstein, O; Bialer, M; Radatz, M; Nau, H; Yagen, B
    Enantioselective synthesis and teratogenicity of propylisopropyl acetamide, a CNS-active chiral amide analogue of valproic acid
    CHIRALITY
    
    O. Spiegelstein et al., "Enantioselective synthesis and teratogenicity of propylisopropyl acetamide, a CNS-active chiral amide analogue of valproic acid", CHIRALITY, 11(8), 1999, pp. 645-650
18. Spiegelstein, O; Yagen, B; Levy, RH; Finnell, RH; Bennett, GD; Roeder, M; Schurig, V; Bialer, M
    Stereoselective pharmacokinetics and pharmacodynamics of propylisopropyl acetamide, a CNS-active chiral amide analog of valproic acid
    PHARMACEUTICAL RESEARCH
    
    O. Spiegelstein et al., "Stereoselective pharmacokinetics and pharmacodynamics of propylisopropyl acetamide, a CNS-active chiral amide analog of valproic acid", PHARM RES, 16(10), 1999, pp. 1582-1588
19. Bialer, M
    Pharmacokinetic considerations in the design of better and safer new antiepileptic drugs
    JOURNAL OF CONTROLLED RELEASE
    
    M. Bialer, "Pharmacokinetic considerations in the design of better and safer new antiepileptic drugs", J CONTR REL, 62(1-2), 1999, pp. 187-192
20. Volosov, A; Sintov, A; Bialer, M
    Stereoselective pharmacokinetic analysis of the antiepileptic 10-hydroxycarbazepine in dogs
    THERAPEUTIC DRUG MONITORING
    
    A. Volosov et al., "Stereoselective pharmacokinetic analysis of the antiepileptic 10-hydroxycarbazepine in dogs", THER DRUG M, 21(2), 1999, pp. 219-223
21. Volosov, A; Bialer, M
    Use of mean residence time to determine the magnitude of difference between rate constants and to calculate t(max) in the Bateman equation
    BIOPHARMACEUTICS & DRUG DISPOSITION
    
    A. Volosov e M. Bialer, "Use of mean residence time to determine the magnitude of difference between rate constants and to calculate t(max) in the Bateman equation", BIOPHARM DR, 20(1), 1999, pp. 3-9
22. Spiegelstein, O; Yagen, B; Bialer, M
    Structure-pharmacokinetic-pharmacodynamic relationships of N-alkyl derivatives of the new antiepileptic drug valproyl glycinamide
    EPILEPSIA
    
    O. Spiegelstein et al., "Structure-pharmacokinetic-pharmacodynamic relationships of N-alkyl derivatives of the new antiepileptic drug valproyl glycinamide", EPILEPSIA, 40(5), 1999, pp. 545-552
23. Volosov, A; Sun, XD; Perucca, E; Yagen, B; Sintov, A; Perucca, E; Yagen, B; Sintov, A; Bialer, M
    Enantioselective pharmacokinetics of 10-hydroxycarbazepine after oral administration of oxcarbazepine to healthy Chinese subjects
    CLINICAL PHARMACOLOGY & THERAPEUTICS
    
    A. Volosov et al., "Enantioselective pharmacokinetics of 10-hydroxycarbazepine after oral administration of oxcarbazepine to healthy Chinese subjects", CLIN PHARM, 66(6), 1999, pp. 547-553
24. BLOTNIK S; BERGMAN F; BIALER M
    DISPOSITION OF 2 TETRAMETHYLCYCLOPROPANE ANALOGS OF VALPROMIDE IN THEBRAIN, LIVER, PLASMA AND URINE OF RATS
    European journal of pharmaceutical sciences
    
    S. Blotnik et al., "DISPOSITION OF 2 TETRAMETHYLCYCLOPROPANE ANALOGS OF VALPROMIDE IN THEBRAIN, LIVER, PLASMA AND URINE OF RATS", European journal of pharmaceutical sciences, 6(2), 1998, pp. 93-98
25. BIALER M; ARCAVI L; SUSSAN S; VOLOSOV A; YACOBI A; MOROS D; LEVITT B; LAOR A
    EXISTING AND NEW CRITERIA FOR BIOEQUIVALENCE EVALUATION OF NEW CONTROLLED-RELEASE (CR) PRODUCTS OF CARBAMAZEPINE
    Epilepsy research
    
    M. Bialer et al., "EXISTING AND NEW CRITERIA FOR BIOEQUIVALENCE EVALUATION OF NEW CONTROLLED-RELEASE (CR) PRODUCTS OF CARBAMAZEPINE", Epilepsy research, 32(3), 1998, pp. 371-378
26. RADATZ M; EHLERS K; YAGEN B; BIALER M; NAU H
    VALNOCTAMIDE, VALPROMIDE AND VALNOCTIC ACID ARE MUCH LESS TERATOGENICIN MICE THAN VALPROIC ACID
    Epilepsy research
    
    M. Radatz et al., "VALNOCTAMIDE, VALPROMIDE AND VALNOCTIC ACID ARE MUCH LESS TERATOGENICIN MICE THAN VALPROIC ACID", Epilepsy research, 30(1), 1998, pp. 41-48
27. BIALER M; LEVY RH; PERUCCA E
    DOES CARBAMAZEPINE HAVE A NARROW THERAPEUTIC PLASMA-CONCENTRATION RANGE
    Therapeutic drug monitoring
    
    M. Bialer et al., "DOES CARBAMAZEPINE HAVE A NARROW THERAPEUTIC PLASMA-CONCENTRATION RANGE", Therapeutic drug monitoring, 20(1), 1998, pp. 56-59
28. BIALER M; YACOBI A; MOROS D; LEVITT B; HOULE JM; MUNSAKA MS
    CRITERIA TO ASSESS IN-VIVO PERFORMANCE AND BIOEQUIVALENCE OF GENERIC CONTROLLED-RELEASE FORMULATIONS OF CARBAMAZEPINE
    Epilepsia
    
    M. Bialer et al., "CRITERIA TO ASSESS IN-VIVO PERFORMANCE AND BIOEQUIVALENCE OF GENERIC CONTROLLED-RELEASE FORMULATIONS OF CARBAMAZEPINE", Epilepsia, 39(5), 1998, pp. 513-519
29. SPIEGELSTEIN O; BIALER M; YAGEN B
    ISOLATION OF N,N-DIALKYLATED DERIVATIVES OF VALPROYLGLYCINAMIDE FROM DOG PLASMA BY ACTIVE CHARCOAL ADSORPTION AND THEIR QUANTIFICATION BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
    Journal of chromatography B. Biomedical sciences and applications
    
    O. Spiegelstein et al., "ISOLATION OF N,N-DIALKYLATED DERIVATIVES OF VALPROYLGLYCINAMIDE FROM DOG PLASMA BY ACTIVE CHARCOAL ADSORPTION AND THEIR QUANTIFICATION BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY", Journal of chromatography B. Biomedical sciences and applications, 698(1-2), 1997, pp. 195-200
30. PETRIKOVSKY BM; GROSS B; BIALER M; SOLAMANZADEH K; SIMHAEE E
    PRENATAL-DIAGNOSIS OF PSEUDOTHALIDOMIDE SYNDROME IN CONSECUTIVE PREGNANCIES OF A CONSANGUINEOUS COUPLE
    Ultrasound in obstetrics & gynecology
    
    B.M. Petrikovsky et al., "PRENATAL-DIAGNOSIS OF PSEUDOTHALIDOMIDE SYNDROME IN CONSECUTIVE PREGNANCIES OF A CONSANGUINEOUS COUPLE", Ultrasound in obstetrics & gynecology, 10(6), 1997, pp. 425-428
31. BIALER M; JOHANNESSEN SI; KUPFERBERG HJ; LEVY RH; LOISEAU P; PERUCCA E
    CONFERENCE REPORT - PROGRESS REPORT ON NEW ANTIEPILEPTIC DRUGS - A SUMMARY OF THE 3RD EILAT-CONFERENCE (VOL 25, PG 299, 1996)
    Epilepsy research
    
    M. Bialer et al., "CONFERENCE REPORT - PROGRESS REPORT ON NEW ANTIEPILEPTIC DRUGS - A SUMMARY OF THE 3RD EILAT-CONFERENCE (VOL 25, PG 299, 1996)", Epilepsy research, 26(3), 1997, pp. 465-465
32. BLOTNIK S; BERGMAN F; BIALER M
    THE DISPOSITION OF VALPROYL GLYCINAMIDE AND VALPROYL GLYCINE IN RATS
    Pharmaceutical research
    
    S. Blotnik et al., "THE DISPOSITION OF VALPROYL GLYCINAMIDE AND VALPROYL GLYCINE IN RATS", Pharmaceutical research, 14(7), 1997, pp. 873-878
33. LEVI M; YAGEN B; BIALER M
    PHARMACOKINETICS AND ANTIEPILEPTIC ACTIVITY OF VALPROYL HYDROXAMIC ACID-DERIVATIVES
    Pharmaceutical research
    
    M. Levi et al., "PHARMACOKINETICS AND ANTIEPILEPTIC ACTIVITY OF VALPROYL HYDROXAMIC ACID-DERIVATIVES", Pharmaceutical research, 14(2), 1997, pp. 213-217
34. SHALON L; MARKOWITZ J; BIALER M; KAHN E; WEINBLATT M; GIARDIELLO FM; LUCE MC; DAUM F
    OVARIAN NEOPLASM AND ENDOMETRIOID CARCINOMA IN A PATIENT WITH TURCOT-SYNDROME
    Journal of pediatric gastroenterology and nutrition
    
    L. Shalon et al., "OVARIAN NEOPLASM AND ENDOMETRIOID CARCINOMA IN A PATIENT WITH TURCOT-SYNDROME", Journal of pediatric gastroenterology and nutrition, 25(2), 1997, pp. 224-227
35. HADAD S; BIALER M
    PHARMACOKINETIC ANALYSIS AND ANTIEPILEPTIC ACTIVITY OF 2 NEW ISOMERS OF N-VALPROYL GLYCINAMIDE
    Biopharmaceutics & drug disposition
    
    S. Hadad e M. Bialer, "PHARMACOKINETIC ANALYSIS AND ANTIEPILEPTIC ACTIVITY OF 2 NEW ISOMERS OF N-VALPROYL GLYCINAMIDE", Biopharmaceutics & drug disposition, 18(7), 1997, pp. 557-566
36. LUCE M; KAHN E; BIALER M; SHALON L; MARKOWITZ J
    A HOMOZYGOUS HPMS2 MUTATION IN 2 PATIENTS WITH TURCOT-SYNDROME (TS)
    Laboratory investigation
    
    M. Luce et al., "A HOMOZYGOUS HPMS2 MUTATION IN 2 PATIENTS WITH TURCOT-SYNDROME (TS)", Laboratory investigation, 76(1), 1997, pp. 21-21
37. BAREL S; YAGEN B; SCHURIG V; SOBACK S; PISANI F; PERUCCA E; BIALER M
    STEREOSELECTIVE PHARMACOKINETIC ANALYSIS OF VALNOCTAMIDE IN HEALTHY-SUBJECTS AND IN PATIENTS WITH EPILEPSY
    Clinical pharmacology and therapeutics
    
    S. Barel et al., "STEREOSELECTIVE PHARMACOKINETIC ANALYSIS OF VALNOCTAMIDE IN HEALTHY-SUBJECTS AND IN PATIENTS WITH EPILEPSY", Clinical pharmacology and therapeutics, 61(4), 1997, pp. 442-449
38. PETRIKOVSKY B; GROSS B; SPINAZZOLA R; BIALER M
    SINGLE-NEEDLE INSERTION TECHNIQUE FOR THORACENTESIS FOR BILATERAL PLEURAL EFFUSIONS
    Fetal diagnosis and therapy
    
    B. Petrikovsky et al., "SINGLE-NEEDLE INSERTION TECHNIQUE FOR THORACENTESIS FOR BILATERAL PLEURAL EFFUSIONS", Fetal diagnosis and therapy, 11(1), 1996, pp. 26-31
39. BIALER M; JOHANNESSEN SI; KUPFERBERG HJ; LEVY RH; LOISEAU P; PERUCCA E
    PROGRESS REPORT ON NEW ANTIEPILEPTIC DRUGS - A SUMMARY OF THE 3RD EILAT CONFERENCE
    Epilepsy research
    
    M. Bialer et al., "PROGRESS REPORT ON NEW ANTIEPILEPTIC DRUGS - A SUMMARY OF THE 3RD EILAT CONFERENCE", Epilepsy research, 25(3), 1996, pp. 299-319
40. BIALER M; HADAD S; KADRY B; ABDULHAI A; HAJYEHIA A; STERLING J; HERZIG Y; YAGEN B
    PHARMACOKINETIC ANALYSIS AND ANTIEPILEPTIC ACTIVITY OF TETRAMETHYLCYCLOPROPANE ANALOGS OF VALPROMIDE
    Pharmaceutical research
    
    M. Bialer et al., "PHARMACOKINETIC ANALYSIS AND ANTIEPILEPTIC ACTIVITY OF TETRAMETHYLCYCLOPROPANE ANALOGS OF VALPROMIDE", Pharmaceutical research, 13(2), 1996, pp. 284-289
41. PERUCCA E; BIALER M
    THE CLINICAL PHARMACOKINETICS OF THE NEWER ANTIEPILEPTIC DRUGS - FOCUS ON TOPIRAMATE, ZONISAMIDE AND TIAGABINE
    Clinical pharmacokinetics
    
    E. Perucca e M. Bialer, "THE CLINICAL PHARMACOKINETICS OF THE NEWER ANTIEPILEPTIC DRUGS - FOCUS ON TOPIRAMATE, ZONISAMIDE AND TIAGABINE", Clinical pharmacokinetics, 31(1), 1996, pp. 29-46
42. GILBERT F; LI Z; ARZIMANOGLOU I; BIALER M; DENNING C; GORVOY J; HONOROF J; ORES C; QUITTELL L; ROSSOFF L; VALVERDE K
    CLINICAL SPECTRUM IN HOMOZYGOTES AND COMPOUND HETEROZYGOTES INHERITING CYSTIC-FIBROSIS MUTATION 3849-GREATER-THAN-T - SIGNIFICANCE FOR GENETICISTS (VOL 58, PG 356, 1995)(10KBC)
    American journal of medical genetics
    
    F. Gilbert et al., "CLINICAL SPECTRUM IN HOMOZYGOTES AND COMPOUND HETEROZYGOTES INHERITING CYSTIC-FIBROSIS MUTATION 3849-GREATER-THAN-T - SIGNIFICANCE FOR GENETICISTS (VOL 58, PG 356, 1995)(10KBC)", American journal of medical genetics, 64(3), 1996, pp. 527-527
43. BIALER M; KADRY B; ABDULHAI A; HAJYEHIA A; STERLING J; HERZIG Y; SHIRVAN M
    PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSIS OF (E)-2-ENE VALPROYL DERIVATIVES OF GLYCINE AND VALPROYL DERIVATIVES OF NIPECOTIC ACID
    Biopharmaceutics & drug disposition
    
    M. Bialer et al., "PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSIS OF (E)-2-ENE VALPROYL DERIVATIVES OF GLYCINE AND VALPROYL DERIVATIVES OF NIPECOTIC ACID", Biopharmaceutics & drug disposition, 17(7), 1996, pp. 565-575
44. BLOTNIK S; BERGMAN F; BIALER M
    DISPOSITION OF VALPROMIDE, VALPROIC ACID, AND VALNOCTAMIDE IN THE BRAIN, LIVER, PLASMA, AND URINE OF RATS
    Drug metabolism and disposition
    
    S. Blotnik et al., "DISPOSITION OF VALPROMIDE, VALPROIC ACID, AND VALNOCTAMIDE IN THE BRAIN, LIVER, PLASMA, AND URINE OF RATS", Drug metabolism and disposition, 24(5), 1996, pp. 560-564
45. STABLES JP; BIALER M; JOHANNESSEN SI; KUPFERBERG HJ; LEVY RH; LOISEAU P; PERUCCA E
    PROGRESS REPORT ON NEW ANTIEPILEPTIC DRUGS A SUMMARY OF THE 2ND EILAT-CONFERENCE
    Epilepsy research
    
    J.P. Stables et al., "PROGRESS REPORT ON NEW ANTIEPILEPTIC DRUGS A SUMMARY OF THE 2ND EILAT-CONFERENCE", Epilepsy research, 22(3), 1995, pp. 235-246
46. HADAD S; BIALER M
    PHARMACOKINETIC ANALYSIS AND ANTIEPILEPTIC ACTIVITY OF N-VALPROYL DERIVATIVES OF GABA AND GLYCINE
    Pharmaceutical research
    
    S. Hadad e M. Bialer, "PHARMACOKINETIC ANALYSIS AND ANTIEPILEPTIC ACTIVITY OF N-VALPROYL DERIVATIVES OF GABA AND GLYCINE", Pharmaceutical research, 12(6), 1995, pp. 905-910
47. TAFF IP; ZITO J; BIALER M; MONTERA L
    MAGNETIC-RESONANCE-IMAGING OF THE CENTRAL-NERVOUS-SYSTEM IN PEDIATRICNEUROFIBROMATOSIS TYPE-1
    Annals of neurology
    
    I.P. Taff et al., "MAGNETIC-RESONANCE-IMAGING OF THE CENTRAL-NERVOUS-SYSTEM IN PEDIATRICNEUROFIBROMATOSIS TYPE-1", Annals of neurology, 38(2), 1995, pp. 352-352
48. GILBERT F; LI Z; ARZIMANOGLOU I; BIALER M; DENNING C; GORVOY J; HONOROF J; ORES C; QUITTELL L; ROSSOFF L; VALVERDE K
    CLINICAL SPECTRUM IN HOMOZYGOTES AND COMPOUND HETEROZYGOTES INHERITING CYSTIC-FIBROSIS MUTATION 3849-GREATER-THAN-T - SIGNIFICANCE FOR GENETICISTS(10KBC)
    American journal of medical genetics
    
    F. Gilbert et al., "CLINICAL SPECTRUM IN HOMOZYGOTES AND COMPOUND HETEROZYGOTES INHERITING CYSTIC-FIBROSIS MUTATION 3849-GREATER-THAN-T - SIGNIFICANCE FOR GENETICISTS(10KBC)", American journal of medical genetics, 58(4), 1995, pp. 356-359
49. SAMARA E; AVNIR D; LADKANI D; BIALER M
    PHARMACOKINETIC ANALYSIS OF DIETHYLCARBONATE PRODRUGS OF IBUPROFEN AND NAPROXEN
    Biopharmaceutics & drug disposition
    
    E. Samara et al., "PHARMACOKINETIC ANALYSIS OF DIETHYLCARBONATE PRODRUGS OF IBUPROFEN AND NAPROXEN", Biopharmaceutics & drug disposition, 16(3), 1995, pp. 201-210
50. BIALER M; SUSSAN S; SALACH OA; DANENBERG HD; BENDAVID J; GIBOR Y; LAOR A
    CRITERIA TO ASSESS IN-VIVO PERFORMANCE OF SUSTAINED-RELEASE PRODUCTS - APPLICATION TO DILTIAZEM FORMULATIONS
    Journal of pharmaceutical sciences
    
    M. Bialer et al., "CRITERIA TO ASSESS IN-VIVO PERFORMANCE OF SUSTAINED-RELEASE PRODUCTS - APPLICATION TO DILTIAZEM FORMULATIONS", Journal of pharmaceutical sciences, 84(10), 1995, pp. 1160-1163
51. HADAD S; BIALER M
    PHARMACOKINETIC ANALYSIS AND ANTIEPILEPTIC ACTIVITY OF NOVEL VALPROATE DERIVATIVES OF GABA AND GLYCINE
    Epilepsia
    
    S. Hadad e M. Bialer, "PHARMACOKINETIC ANALYSIS AND ANTIEPILEPTIC ACTIVITY OF NOVEL VALPROATE DERIVATIVES OF GABA AND GLYCINE", Epilepsia, 36, 1995, pp. 41-41
52. ABUSALACH O; HADAD S; HAJYEHIA A; SUSSAN S; BIALER M
    COMPARATIVE PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSIS OF PHTHLALOYL GLYCINE DERIVATIVES WITH POTENTIAL ANTIEPILEPTIC ACTIVITY
    Epilepsia
    
    O. Abusalach et al., "COMPARATIVE PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSIS OF PHTHLALOYL GLYCINE DERIVATIVES WITH POTENTIAL ANTIEPILEPTIC ACTIVITY", Epilepsia, 36, 1995, pp. 163-163
53. BIALER M; HAJYEHIA A; BADIR K; HADAD S
    CAN WE DEVELOP IMPROVED DERIVATIVES OF VALPROIC ACID
    Pharmacy world & science
    
    M. Bialer et al., "CAN WE DEVELOP IMPROVED DERIVATIVES OF VALPROIC ACID", Pharmacy world & science, 16(1), 1994, pp. 2-6
54. BIALER M; PHARAJ Z; ZUCKERMAN S; RAZ I; ABRAMSKY O; STERLING J; LADKANI D
    PHARMACOKINETIC ANALYSIS OF VALDICE - A DIETHYLCARBONATE PRODRUG OF VALPROIC ACID
    European journal of pharmaceutical sciences
    
    M. Bialer et al., "PHARMACOKINETIC ANALYSIS OF VALDICE - A DIETHYLCARBONATE PRODRUG OF VALPROIC ACID", European journal of pharmaceutical sciences, 2(3), 1994, pp. 239-244
55. ABUSALACH O; HADAD S; HAJYEHIA A; SUSSAN S; BIALER M
    COMPARATIVE PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSIS OF PHTHALOYLGLYCINE DERIVATIVES WITH POTENTIAL ANTIEPILEPTIC ACTIVITY
    Pharmaceutical research
    
    O. Abusalach et al., "COMPARATIVE PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSIS OF PHTHALOYLGLYCINE DERIVATIVES WITH POTENTIAL ANTIEPILEPTIC ACTIVITY", Pharmaceutical research, 11(10), 1994, pp. 1429-1434
56. WEINBLATT M; PETRIKOVSKY B; BIALER M; KOCHEN J; HARPER R
    PRENATAL EVALUATION AND IN-UTERO PLATELET TRANSFUSION FOR THROMBOCYTOPENIA ABSENT RADII SYNDROME
    Prenatal diagnosis
    
    M. Weinblatt et al., "PRENATAL EVALUATION AND IN-UTERO PLATELET TRANSFUSION FOR THROMBOCYTOPENIA ABSENT RADII SYNDROME", Prenatal diagnosis, 14(9), 1994, pp. 892-896
57. BAREL S; YAGEN B; BIALER M
    PHARMACOKINETIC PROFILE OF CONJUGATED VERRUCAROL URINARY METABOLITES IN DOGS
    Biopharmaceutics & drug disposition
    
    S. Barel et al., "PHARMACOKINETIC PROFILE OF CONJUGATED VERRUCAROL URINARY METABOLITES IN DOGS", Biopharmaceutics & drug disposition, 15(7), 1994, pp. 609-616
58. BIALER M; HADAD S; GOLOMB G; BAREL S; SAMARA E; ABUSALACH O; BERKMAN N; DANENBERG HD; BENDAVID J; CARON D; KAPLAN R; TAMIR A; FRIEDMAN M
    PHARMACOKINETIC ANALYSIS OF 2 NEW SUSTAINED-RELEASE PRODUCTS OF DILTIAZEM DESIGNED FOR TWICE-DAILY AND ONCE-DAILY TREATMENT
    Biopharmaceutics & drug disposition
    
    M. Bialer et al., "PHARMACOKINETIC ANALYSIS OF 2 NEW SUSTAINED-RELEASE PRODUCTS OF DILTIAZEM DESIGNED FOR TWICE-DAILY AND ONCE-DAILY TREATMENT", Biopharmaceutics & drug disposition, 15(1), 1994, pp. 45-52
59. SOBACK S; GIPS M; BIALER M; BOR A
    EFFECT OF LACTATION ON SINGLE-DOSE PHARMACOKINETICS OF NORFLOXACIN NICOTINATE IN EWES
    Antimicrobial agents and chemotherapy
    
    S. Soback et al., "EFFECT OF LACTATION ON SINGLE-DOSE PHARMACOKINETICS OF NORFLOXACIN NICOTINATE IN EWES", Antimicrobial agents and chemotherapy, 38(10), 1994, pp. 2336-2339
60. PERUCCA E; GATTI G; CIPOLLA G; SPINA E; BAREL S; SOBACK S; GIPS M; BIALER M
    INHIBITION OF DIAZEPAM METABOLISM BY FLUVOXAMINE - A PHARMACOKINETIC STUDY IN NORMAL VOLUNTEERS
    Clinical pharmacology and therapeutics
    
    E. Perucca et al., "INHIBITION OF DIAZEPAM METABOLISM BY FLUVOXAMINE - A PHARMACOKINETIC STUDY IN NORMAL VOLUNTEERS", Clinical pharmacology and therapeutics, 56(5), 1994, pp. 471-476
61. GABIZON AA; BARENHOLZ Y; BIALER M
    PROLONGATION OF THE CIRCULATION TIME OF DOXORUBICIN ENCAPSULATED IN LIPOSOMES CONTAINING A POLYETHYLENE GLYCOL-DERIVATIZED PHOSPHOLIPID - PHARMACOKINETIC STUDIES IN RODENTS AND DOGS
    Pharmaceutical research
    
    A.A. Gabizon et al., "PROLONGATION OF THE CIRCULATION TIME OF DOXORUBICIN ENCAPSULATED IN LIPOSOMES CONTAINING A POLYETHYLENE GLYCOL-DERIVATIZED PHOSPHOLIPID - PHARMACOKINETIC STUDIES IN RODENTS AND DOGS", Pharmaceutical research, 10(5), 1993, pp. 703-708
62. YAGEN B; BIALER M
    METABOLISM AND PHARMACOKINETICS OF T-2 TOXIN AND RELATED TRICHOTHECENES
    Drug metabolism reviews
    
    B. Yagen e M. Bialer, "METABOLISM AND PHARMACOKINETICS OF T-2 TOXIN AND RELATED TRICHOTHECENES", Drug metabolism reviews, 25(3), 1993, pp. 281-323
63. BIALER M
    COMPARATIVE PHARMACOKINETICS OF THE NEWER ANTIEPILEPTIC DRUGS
    Clinical pharmacokinetics
    
    M. Bialer, "COMPARATIVE PHARMACOKINETICS OF THE NEWER ANTIEPILEPTIC DRUGS", Clinical pharmacokinetics, 24(6), 1993, pp. 441-452
64. PISANI F; HAJYEHIA A; FAZIO A; ARTESI C; OTERI G; PERUCCA E; KROETZ DL; LEVY RH; BIALER M
    CARBAMAZEPINE VALNOCTAMIDE INTERACTION IN EPILEPTIC PATIENTS - IN-VITRO IN-VIVO CORRELATION
    Epilepsia
    
    F. Pisani et al., "CARBAMAZEPINE VALNOCTAMIDE INTERACTION IN EPILEPTIC PATIENTS - IN-VITRO IN-VIVO CORRELATION", Epilepsia, 34(5), 1993, pp. 954-959
65. BALE A; BIALER M; GAILANI M; DOKRAS A
    PRENATAL, PRESYMPTOMATIC, AND PREIMPLANTATION DIAGNOSIS OF GORLIN SYNDROME
    American journal of human genetics
    
    A. Bale et al., "PRENATAL, PRESYMPTOMATIC, AND PREIMPLANTATION DIAGNOSIS OF GORLIN SYNDROME", American journal of human genetics, 53(3), 1993, pp. 1381-1381
66. SAMARA E; BIALER M; HARVEY DJ
    METABOLISM OF CANNABIDIOL BY THE RAT
    European journal of drug metabolism and pharmacokinetics
    
    E. Samara et al., "METABOLISM OF CANNABIDIOL BY THE RAT", European journal of drug metabolism and pharmacokinetics, 16(4), 1991, pp. 305-313